Despite formal acceptance of guidelines, there remains poor implementation and significant variability in anticoagulation management after biological aortic valve replacement across Dutch cardiothoracic centres.
No takes yet. Share an insight, caveat, or question.
Variability in post-biological AVR anticoagulation persists despite guideline knowledge; leaves open optimal regimens and implementation barriers.
Bekker et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: